ARRB2 promotes colorectal cancer growth through triggering WTAP

Colorectal cancer (CRC) is one of the most lethal cancers worldwide. The expression of beta-arrestin2 (beta-Arr2, ARRB2) in CRC has been well investigated; however, its exact mechanism causing the cancer progression remains unclear. In this study, we discovered that the expression level of ARRB2 was significantly upregulated in CRC as compared to the normal tissues by employing the Cancer Genome Atlas (TCGA) data, western blot analysis, and immunohistochemistry. Furthermore, the level of ARRB2 was correlated with the patients' overall survival by Kaplan-Meier analysis. The higher expression of ARRB2 promoted CRC cell growth, enhanced the cell motility, and blocked cell apoptosis, which is crucial for tumor growth. Lastly, the suppression of ARRB2 expression was enough to attenuate the progression of CRC induced by azoxymethane/dextran sodium sulfate. Interestingly, we also found that the knockdown of ARRB2 decreased several cancer pathways mediated by the expression of Wilms tumor 1 associated protein (WTAP), which led to the inhibition of cell proliferation and migration. Altogether, our results demonstrated that ARRB2 promoted the growth and migration of CRC cells by regulating the WTAP expression.

Automated summary

In this study, it was found that the upregulation of ARRB2 in CRC was associated with patient survival, promoting cell growth and migration while inhibiting apoptosis. Suppression of ARRB2 expression attenuated CRC progression, demonstrating its role in regulating cancer pathways through WTAP expression.